RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 9.5863

Change

+0.01 (+0.15)%

Market Cap

N/A

Volume

2.19K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

N/A

USD 1.12B
SOXS Direxion Daily Semiconductor B..

-0.95 (-4.33%)

USD 0.85B
PSQ ProShares Short QQQ

-0.04 (-0.10%)

USD 0.58B
SPXU ProShares UltraPro Short S&P50..

-0.01 (-0.04%)

USD 0.54B
SDOW ProShares UltraPro Short Dow30

-0.04 (-0.30%)

USD 0.31B
DOG ProShares Short Dow30

-0.01 (-0.04%)

USD 0.16B
SPDN Direxion Daily S&P 500® Bear ..

-0.01 (-0.09%)

USD 0.16B
RWM ProShares Short Russell2000

+0.02 (+0.10%)

USD 0.15B
DUST Direxion Daily Gold Miners Ind..

+0.02 (+0.39%)

USD 0.12B
FNGD MicroSectors FANG+ Index -3X I..

-0.39 (-1.70%)

USD 0.11B

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.65% 62% D 10% F
Dividend Return 3.50% 60% D- 61% D-
Total Return -16.14% 64% D 11% F
Trailing 12 Months  
Capital Gain -28.78% 70% C- 6% D-
Dividend Return 4.01% 68% D+ 53% F
Total Return -24.77% 70% C- 7% C-
Trailing 5 Years  
Capital Gain -79.07% 56% F 4% F
Dividend Return 2.14% 53% F 6% D-
Total Return -76.93% 55% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 1.97% N/A N/A 45% F
Dividend Return 3.02% N/A N/A 39% F
Total Return 1.04% N/A N/A 24% F
Risk Return Profile  
Volatility (Standard Deviation) 249.65% N/A N/A 3% F
Risk Adjusted Return 1.21% N/A N/A 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike